ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018

July 17, 2018

LYON, France and CAMBRIDGE, Mass., July  17, 2018  (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) announced that its 2018 Annual General Meeting was held in Lyon on Thursday, June 28, 2018.At the meeting, all resolutions for which management recommende

Read More

ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia

June 24, 2018

(GLOBE NEWSWIRE via COMTEX) --- Focuses development efforts on solid tumor indications - Confirms planned launch of company-sponsored randomized Phase 2 trial in first-line pancreatic cancer, in addition to ongoing launch of Phase 3 trial in second-line pancreatic cancer. -

Read More